NDA 50593, held by Hospira. Erythromycin.
As of Nov 14, 2026, NDA 50593 (Eryc Sprinkles), held by Hospira, was first approved by FDA on Jul 22, 1985, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 22, 1985 | Original applicationNew dosage form · Standard review | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Eryc Sprinkles125MG · capsule, delayed rel pellets;oral | Erythromycin | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
